Non-melanoma Skin Cancer (NMSC)
Oncology·MeSH: Melanoma
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Non-melanoma Skin Cancer (NMSC)?
There are 1 clinical trial targeting Non-melanoma Skin Cancer (NMSC) tracked by BioSniper.
What is the prevalence of Non-melanoma Skin Cancer (NMSC)?
The estimated prevalence of Non-melanoma Skin Cancer (NMSC) is approximately 75.0 per 100,000 population.
Deep-dive into Non-melanoma Skin Cancer (NMSC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis